News

NIH and FDA Release a Draft Clinical Trial Protocol Template for Public Discussion


 

References

To help clinical investigators make clinical trials more efficient, the Food and Drug Administration (FDA) and National Institutes of Health (NIH) have developed a draft clinical trial protocol template. The hope is to facilitate creativity and innovation, while also promoting efficiency to optimize clinical trial success. The template is posted online and public comments will be accepted until April 17.

Recommended Reading

Dr. Califf Is Confirmed as FDA Commissioner; NORD Issues Statement
MDedge Dermatology
FDA Offers New Resource on Biosimilars for Health Care Providers
MDedge Dermatology
IOM Report: Mitochondrial Replacement “Ethically Permissible”
MDedge Dermatology
Topical allantoin cream speeds wound healing in epidermolysis bullosa
MDedge Dermatology
Colombia reports first Zika deaths, all in medically compromised patients
MDedge Dermatology
Congenital Self-healing Reticulohistiocytosis: An Underreported Entity
MDedge Dermatology
NORD Announces 2016 Rare Impact Award Recipients
MDedge Dermatology
Free Summer Camp For Families of Children With Rare Diseases
MDedge Dermatology
NORD Speaks on Behalf of Continued Funding for NIH Undiagnosed Diseases Network
MDedge Dermatology
News From NORD Round-Up: April 2016
MDedge Dermatology